Seizinger Bernd R.'s Form 4 filing
Oncolytics Biotech Inc (ONCY) · filed Jan 20, 2026
- Accession no.
- 0001493152-26-002879
- Filed
- Jan 20, 2026
- Trade date
- Jan 16, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $104.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Seizinger Bernd R.CIK 0001789042 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 16, 2026 | Common Shares | PPurchaseAcquired | +100,000 | $1.04 | +$104,000 | 466,991 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.